TMEFF1 is a neuron-specific restriction factor for herpes simplex virus.


Journal

Nature
ISSN: 1476-4687
Titre abrégé: Nature
Pays: England
ID NLM: 0410462

Informations de publication

Date de publication:
24 Jul 2024
Historique:
received: 09 08 2022
accepted: 04 06 2024
medline: 26 7 2024
pubmed: 26 7 2024
entrez: 24 7 2024
Statut: aheadofprint

Résumé

The brain is highly sensitive to damage caused by infection and inflammation

Identifiants

pubmed: 39048823
doi: 10.1038/s41586-024-07670-z
pii: 10.1038/s41586-024-07670-z
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© 2024. The Author(s), under exclusive licence to Springer Nature Limited.

Références

Stahl, J. P. & Mailles, A. Herpes simplex virus encephalitis update. Curr. Opin. Infect. Dis. 32, 239–243 (2019).
pubmed: 30921087 doi: 10.1097/QCO.0000000000000554
Crow, Y. J. & Manel, N. Aicardi–Goutières syndrome and the type I interferonopathies. Nat. Rev. Immunol. 15, 429–440 (2015).
pubmed: 26052098 doi: 10.1038/nri3850
Liesegang, T. J. Herpes simplex virus epidemiology and ocular importance. Cornea 20, 1–13 (2001).
pubmed: 11188989 doi: 10.1097/00003226-200101000-00001
Geraghty, R. J., Krummenacher, C., Cohen, G. H., Eisenberg, R. J. & Spear, P. G. Entry of alphaherpesviruses mediated by poliovirus receptor-related protein 1 and poliovirus receptor. Science 280, 1618–1620 (1998).
pubmed: 9616127 doi: 10.1126/science.280.5369.1618
Arii, J. et al. Non-muscle myosin IIA is a functional entry receptor for herpes simplex virus-1. Nature 467, 859–862 (2010).
pubmed: 20944748 doi: 10.1038/nature09420
Arii, J., Hirohata, Y., Kato, A. & Kawaguchi, Y. Nonmuscle myosin heavy chain IIb mediates herpes simplex virus 1 entry. J. Virol. 89, 1879–1888 (2015).
pubmed: 25428876 doi: 10.1128/JVI.03079-14
Casanova, J. L. Human genetic basis of interindividual variability in the course of infection. Proc. Natl Acad. Sci. USA 112, E7118–E7127 (2015).
pubmed: 26621739 pmcid: 4697415 doi: 10.1073/pnas.1521644112
Paludan, S. R., Pradeu, T., Master, S. & Mogensen, T. H. Constitutive immune mechanisms: mediators of host defence and immune regulation. Nat. Rev. Immunol. 21, 137–150 (2021).
pubmed: 32782357 doi: 10.1038/s41577-020-0391-5
Zhang, S. Y. et al. TLR3 deficiency in patients with herpes simplex encephalitis. Science 317, 1522–1527 (2007).
pubmed: 17872438 doi: 10.1126/science.1139522
Herman, M. et al. Heterozygous TBK1 mutations impair TLR3 immunity and underlie herpes simplex encephalitis of childhood. J. Exp. Med. 209, 1567–1582 (2012).
pubmed: 22851595 pmcid: 3428952 doi: 10.1084/jem.20111316
Andersen, L. L. et al. Functional IRF3 deficiency in a patient with herpes simplex encephalitis. J. Exp. Med. 212, 1371–1379 (2015).
pubmed: 26216125 pmcid: 4548062 doi: 10.1084/jem.20142274
Bastard, P. et al. Herpes simplex encephalitis in a patient with a distinctive form of inherited IFNAR1 deficiency. J. Clin. Investig. https://doi.org/10.1172/JCI139980 (2021).
Zhang, S. Y. et al. Inborn errors of RNA lariat metabolism in humans with brainstem viral infection. Cell 172, 952–965 (2018).
pubmed: 29474921 pmcid: 5886375 doi: 10.1016/j.cell.2018.02.019
Lafaille, F. G. et al. Human SNORA31 variations impair cortical neuron-intrinsic immunity to HSV-1 and underlie herpes simplex encephalitis. Nat. Med. 25, 1873–1884 (2019).
pubmed: 31806906 pmcid: 7376819 doi: 10.1038/s41591-019-0672-3
Chakraborty, S., Nazmi, A., Dutta, K. & Basu, A. Neurons under viral attack: victims or warriors? Neurochem. Int. 56, 727–735 (2010).
pubmed: 20206655 pmcid: 7115389 doi: 10.1016/j.neuint.2010.02.016
Paludan, S. R. & Mogensen, T. H. Constitutive and latent immune mechanisms exert ‘silent’ control of virus infections in the central nervous system. Curr. Opin. Immunol. 72, 158–166 (2021).
pubmed: 34062364 doi: 10.1016/j.coi.2021.05.004
Yordy, B., Iijima, N., Huttner, A., Leib, D. & Iwasaki, A. A neuron-specific role for autophagy in antiviral defense against herpes simplex virus. Cell Host. Microbe 12, 334–345 (2012).
pubmed: 22980330 pmcid: 3454454 doi: 10.1016/j.chom.2012.07.013
Hait, A. S. et al. Defects in LC3B2 and ATG4A underlie HSV2 meningitis and reveal a critical role for autophagy in antiviral defense in humans. Sci. Immunol. 5, eabc2691 (2020).
pubmed: 33310865 pmcid: 7611067 doi: 10.1126/sciimmunol.abc2691
Shalem, O. et al. Genome-scale CRISPR-Cas9 knockout screening in human cells. Science 343, 84–87 (2014).
pubmed: 24336571 doi: 10.1126/science.1247005
Pillay, S. et al. An essential receptor for adeno-associated virus infection. Nature 530, 108–112 (2016).
pubmed: 26814968 pmcid: 4962915 doi: 10.1038/nature16465
Zhang, R. et al. Mxra8 is a receptor for multiple arthritogenic alphaviruses. Nature 557, 570–574 (2018).
pubmed: 29769725 pmcid: 5970976 doi: 10.1038/s41586-018-0121-3
Park, R. J. et al. A genome-wide CRISPR screen identifies a restricted set of HIV host dependency factors. Nat. Genet. 49, 193–203 (2017).
pubmed: 27992415 doi: 10.1038/ng.3741
Baggen, J. et al. Genome-wide CRISPR screening identifies TMEM106B as a proviral host factor for SARS-CoV-2. Nat. Genet. 53, 435–444 (2021).
pubmed: 33686287 doi: 10.1038/s41588-021-00805-2
Wei, J. et al. Genome-wide CRISPR screens reveal host factors critical for SARS-CoV-2 infection. Cell 184, 76–91 (2021).
pubmed: 33147444 doi: 10.1016/j.cell.2020.10.028
Negorev, D. G., Vladimirova, O. V., Ivanov, A., Rauscher, F. 3rd & Maul, G. G. Differential role of Sp100 isoforms in interferon-mediated repression of herpes simplex virus type 1 immediate-early protein expression. J. Virol. 80, 8019–8029 (2006).
pubmed: 16873258 pmcid: 1563809 doi: 10.1128/JVI.02164-05
Xu, P. & Roizman, B. The SP100 component of ND10 enhances accumulation of PML and suppresses replication and the assembly of HSV replication compartments. Proc. Natl Acad. Sci. USA 114, E3823–E3829 (2017).
pubmed: 28439026 pmcid: 5441741
Reinert, L. S. et al. Sensing of HSV-1 by the cGAS-STING pathway in microglia orchestrates antiviral defense in the CNS. Nat. Commun. 7, 13348 (2016).
pubmed: 27830700 pmcid: 5109551 doi: 10.1038/ncomms13348
Desai, P. & Person, S. Incorporation of the green fluorescent protein into the herpes simplex virus type 1 capsid. J. Virol. 72, 7563–7568 (1998).
pubmed: 9696854 pmcid: 110002 doi: 10.1128/JVI.72.9.7563-7568.1998
Cabantous, S., Terwilliger, T. C. & Waldo, G. S. Protein tagging and detection with engineered self-assembling fragments of green fluorescent protein. Nat. Biotechnol. 23, 102–107 (2005).
pubmed: 15580262 doi: 10.1038/nbt1044
Montgomery, R. I., Warner, M. S., Lum, B. J. & Spear, P. G. Herpes simplex virus-1 entry into cells mediated by a novel member of the TNF/NGF receptor family. Cell 87, 427–436 (1996).
pubmed: 8898196 doi: 10.1016/S0092-8674(00)81363-X
Suenaga, T. et al. Myelin-associated glycoprotein mediates membrane fusion and entry of neurotropic herpesviruses. Proc. Natl Acad. Sci. USA 107, 866–871 (2010).
pubmed: 20080767 doi: 10.1073/pnas.0913351107
Wang, C. et al. Nectin-1 and non-muscle myosin heavy chain-IIB: major mediators of herpes simplex virus-1 entry into corneal nerves. Front. Microbiol. 13, 830699 (2022).
pubmed: 35295302 pmcid: 8919962 doi: 10.3389/fmicb.2022.830699
Horie, M. et al. Identification and characterization of TMEFF2, a novel survival factor for hippocampal and mesencephalic neurons. Genomics 67, 146–152 (2000).
pubmed: 10903839 doi: 10.1006/geno.2000.6228
Kanemoto, N. et al. Expression of TMEFF1 mRNA in the mouse central nervous system: precise examination and comparative studies of TMEFF1 and TMEFF2. Mol. Brain Res. 86, 48–55 (2001).
pubmed: 11165370 doi: 10.1016/S0169-328X(00)00257-6
Laguette, N. et al. SAMHD1 is the dendritic- and myeloid-cell-specific HIV-1 restriction factor counteracted by Vpx. Nature 474, 654–657 (2011).
pubmed: 21613998 pmcid: 3595993 doi: 10.1038/nature10117
Ryoo, J. et al. The ribonuclease activity of SAMHD1 is required for HIV-1 restriction. Nat. Med. 20, 936–941 (2014).
pubmed: 25038827 pmcid: 4318684 doi: 10.1038/nm.3626
Li, K. et al. IFITM proteins restrict viral membrane hemifusion. PLoS Pathog. 9, e1003124 (2013).
pubmed: 23358889 pmcid: 3554583 doi: 10.1371/journal.ppat.1003124
Lanz, C. et al. IFITM3 incorporation sensitizes influenza A virus to antibody-mediated neutralization. J. Exp. Med. https://doi.org/10.1084/jem.20200303 (2021).
Xu, D. et al. PLSCR1 is a cell-autonomous defence factor against SARS-CoV-2 infection. Nature 619, 819–827 (2023).
pubmed: 37438530 pmcid: 10371867 doi: 10.1038/s41586-023-06322-y
Kusano, S. & Ikeda, M. Interaction of phospholipid scramblase 1 with the Epstein-Barr virus protein BZLF1 represses BZLF1-mediated lytic gene transcription. J. Biol. Chem. 294, 15104–15116 (2019).
pubmed: 31434743 pmcid: 6791327 doi: 10.1074/jbc.RA119.008193
Crameri, M. et al. MxB is an interferon-induced restriction factor of human herpesviruses. Nat. Commun. 9, 1980 (2018).
pubmed: 29773792 pmcid: 5958057 doi: 10.1038/s41467-018-04379-2
Orzalli, M. H., Conwell, S. E., Berrios, C., DeCaprio, J. A. & Knipe, D. M. Nuclear interferon-inducible protein 16 promotes silencing of herpesviral and transfected DNA. Proc. Natl Acad. Sci. USA 110, E4492–E4501 (2013).
pubmed: 24198334 pmcid: 3839728 doi: 10.1073/pnas.1316194110
Alandijany, T. Host intrinsic and innate intracellular immunity during herpes simplex virus type 1 (HSV-1) infection. Front. Microbiol. 10, 2611 (2019).
pubmed: 31781083 pmcid: 6856869 doi: 10.3389/fmicb.2019.02611
Brinck Andersen, N. S. et al. Essential role of autophagy in restricting poliovirus infection revealed by identification of an ATG7 defect in a poliomyelitis patient. Autophagy https://doi.org/10.1080/15548627.2020.1831800 (2020).
Rosato, P. C. et al. Neuronal IFN signaling is dispensable for the establishment of HSV-1 latency. Virology 497, 323–327 (2016).
pubmed: 27518540 doi: 10.1016/j.virol.2016.06.016
Cai, W. Z., Person, S., Warner, S. C., Zhou, J. H. & DeLuca, N. A. Linker-insertion nonsense and restriction-site deletion mutations of the gB glycoprotein gene of herpes simplex virus type 1. J. Virol. 61, 714–721 (1987).
pubmed: 3027398 pmcid: 254011 doi: 10.1128/jvi.61.3.714-721.1987
Ligas, M. W. & Johnson, D. C. A herpes simplex virus mutant in which glycoprotein D sequences are replaced by beta-galactosidase sequences binds to but is unable to penetrate into cells. J. Virol. 62, 1486–1494 (1988).
pubmed: 2833603 pmcid: 253172 doi: 10.1128/jvi.62.5.1486-1494.1988
Szpara, M. Isolation of herpes simplex virus nucleocapsid DNA. Methods Mol. Biol. 1144, 31–41 (2014).
pubmed: 24671675 doi: 10.1007/978-1-4939-0428-0_3
Chen, M. et al. Rapid generation of regionally specified CNS neurons by sequential patterning and conversion of human induced pluripotent stem cells. Stem Cell Res. 48, 101945 (2020).
pubmed: 32791483 doi: 10.1016/j.scr.2020.101945
Siletti, K. et al. Transcriptomic diversity of cell types across the adult human brain. Science 382, eadd7046 (2023).
pubmed: 37824663 doi: 10.1126/science.add7046
Sanjana, N. E., Shalem, O. & Zhang, F. Improved vectors and genome-wide libraries for CRISPR screening. Nat. Methods 11, 783–784 (2014).
pubmed: 25075903 pmcid: 4486245 doi: 10.1038/nmeth.3047
Neldeborg, S., Lin, L., Stougaard, M. & Luo, Y. Rapid and efficient gene deletion by CRISPR/Cas9. Methods Mol. Biol. 1961, 233–247 (2019).
pubmed: 30912049 doi: 10.1007/978-1-4939-9170-9_14
Ryo, L. B., Thomsen, E. A. & Mikkelsen, J. G. Production and validation of lentiviral vectors for CRISPR/Cas9 delivery. Methods Mol. Biol. 1961, 93–109 (2019).
pubmed: 30912042 doi: 10.1007/978-1-4939-9170-9_7
Dohner, K. et al. Importin alpha1 is required for nuclear import of herpes simplex virus proteins and capsid assembly in fibroblasts and neurons. PLoS Pathog. 14, e1006823 (2018).
pubmed: 29304174 pmcid: 5773220 doi: 10.1371/journal.ppat.1006823
Reinert, L. S. et al. Brain immune cells undergo cGAS-STING-dependent apoptosis during herpes simplex virus type 1 infection to limit type I interferon production. J. Clin. Invest. 131, e136824 (2021).
pubmed: 32990676 pmcid: 7773356 doi: 10.1172/JCI136824
Ogunjimi, B. et al. Inborn errors in RNA polymerase III underlie severe varicella zoster virus infections. J. Clin. Investig. 127, 3543–3556 (2017).
pubmed: 28783042 pmcid: 5669568 doi: 10.1172/JCI92280
Jumper, J. et al. Highly accurate protein structure prediction with AlphaFold. Nature 596, 583–589 (2021).
pubmed: 34265844 pmcid: 8371605 doi: 10.1038/s41586-021-03819-2
Abramson J. et al. Accurate structure prediction of biomolecular interactions with AlphaFold 3. Nature 630, 493–500 (2024).
Saura, J., Tusell, J. M. & Serratosa, J. High-yield isolation of murine microglia by mild trypsinization. Glia 44, 183–189 (2003).
pubmed: 14603460 doi: 10.1002/glia.10274

Auteurs

Yao Dai (Y)

Key Laboratory of Systems Biomedicine (Ministry of Education), Shanghai Center for Systems Biomedicine, Shanghai Jiao Tong University, Shanghai, China.

Manja Idorn (M)

Department of Biomedicine, Aarhus University, Aarhus, Denmark.
Center for Immunology of Viral Infections, Aarhus, Denmark.

Manutea C Serrero (MC)

Department of Biomedicine, Aarhus University, Aarhus, Denmark.
Center for Immunology of Viral Infections, Aarhus, Denmark.

Xiaoyong Pan (X)

Key Laboratory of System Control and Information Processing (Ministry of Education), Institute of Image Processing and Pattern Recognition, Shanghai Jiao Tong University, Shanghai, China.

Emil A Thomsen (EA)

Department of Biomedicine, Aarhus University, Aarhus, Denmark.
Center for Immunology of Viral Infections, Aarhus, Denmark.

Ryo Narita (R)

Department of Biomedicine, Aarhus University, Aarhus, Denmark.
Center for Immunology of Viral Infections, Aarhus, Denmark.

Muyesier Maimaitili (M)

Department of Biomedicine, Aarhus University, Aarhus, Denmark.
Center for Immunology of Viral Infections, Aarhus, Denmark.

Xiaoqing Qian (X)

School of Biomedical Engineering, Shanghai Jiao Tong University, Shanghai, China.

Marie B Iversen (MB)

Department of Biomedicine, Aarhus University, Aarhus, Denmark.
Center for Immunology of Viral Infections, Aarhus, Denmark.

Line S Reinert (LS)

Department of Biomedicine, Aarhus University, Aarhus, Denmark.
Center for Immunology of Viral Infections, Aarhus, Denmark.

Rasmus K Flygaard (RK)

Department of Molecular Biology and Genetics, Aarhus University, Aarhus, Denmark.

Muwan Chen (M)

Department of Biomedicine, Aarhus University, Aarhus, Denmark.
Center for Immunology of Viral Infections, Aarhus, Denmark.
Danish Research Institute of Translational Neuroscience, Nordic EMBL Partnership for Molecular Medicine, Aarhus University, Aarhus, Denmark.

Xiangning Ding (X)

Department of Biomedicine, Aarhus University, Aarhus, Denmark.
Center for Immunology of Viral Infections, Aarhus, Denmark.

Bao-Cun Zhang (BC)

Department of Biomedicine, Aarhus University, Aarhus, Denmark.
Center for Immunology of Viral Infections, Aarhus, Denmark.

Madalina E Carter-Timofte (ME)

Department of Biomedicine, Aarhus University, Aarhus, Denmark.
Center for Immunology of Viral Infections, Aarhus, Denmark.

Qing Lu (Q)

Key Laboratory for the Genetics of Developmental and Neuropsychiatric Disorders, Ministry of Education, Bio-X Institutes, Shanghai Jiao Tong University, Shanghai, China.

Zhuofan Jiang (Z)

Key Laboratory of Systems Biomedicine (Ministry of Education), Shanghai Center for Systems Biomedicine, Shanghai Jiao Tong University, Shanghai, China.

Yiye Zhong (Y)

Key Laboratory of Systems Biomedicine (Ministry of Education), Shanghai Center for Systems Biomedicine, Shanghai Jiao Tong University, Shanghai, China.

Shuhui Zhang (S)

Key Laboratory of Systems Biomedicine (Ministry of Education), Shanghai Center for Systems Biomedicine, Shanghai Jiao Tong University, Shanghai, China.

Lintai Da (L)

Key Laboratory of Systems Biomedicine (Ministry of Education), Shanghai Center for Systems Biomedicine, Shanghai Jiao Tong University, Shanghai, China.

Jinwei Zhu (J)

Key Laboratory for the Genetics of Developmental and Neuropsychiatric Disorders, Ministry of Education, Bio-X Institutes, Shanghai Jiao Tong University, Shanghai, China.

Mark Denham (M)

Department of Biomedicine, Aarhus University, Aarhus, Denmark.
Danish Research Institute of Translational Neuroscience, Nordic EMBL Partnership for Molecular Medicine, Aarhus University, Aarhus, Denmark.

Poul Nissen (P)

Department of Molecular Biology and Genetics, Aarhus University, Aarhus, Denmark.
Danish Research Institute of Translational Neuroscience, Nordic EMBL Partnership for Molecular Medicine, Aarhus University, Aarhus, Denmark.

Trine H Mogensen (TH)

Department of Biomedicine, Aarhus University, Aarhus, Denmark.
Center for Immunology of Viral Infections, Aarhus, Denmark.
Department of Infectious Diseases, Aarhus University Hospital, Aarhus, Denmark.

Jacob Giehm Mikkelsen (JG)

Department of Biomedicine, Aarhus University, Aarhus, Denmark.
Center for Immunology of Viral Infections, Aarhus, Denmark.

Shen-Ying Zhang (SY)

University of Paris, Imagine Institute, Paris, France.
St. Giles Laboratory of Human Genetics of Infectious Diseases, The Rockefeller University, New York, NY, USA.

Jean-Laurent Casanova (JL)

University of Paris, Imagine Institute, Paris, France.
St. Giles Laboratory of Human Genetics of Infectious Diseases, The Rockefeller University, New York, NY, USA.
Laboratory of Human Genetics of Infectious Diseases, INSERM U1163, Necker Hospital for Sick Children, Paris, France.
Howard Hughes Medical Institute, New York, NY, USA.

Yujia Cai (Y)

Key Laboratory of Systems Biomedicine (Ministry of Education), Shanghai Center for Systems Biomedicine, Shanghai Jiao Tong University, Shanghai, China. yujia.cai@sjtu.edu.cn.
Department of Biomedicine, Aarhus University, Aarhus, Denmark. yujia.cai@sjtu.edu.cn.

Søren R Paludan (SR)

Department of Biomedicine, Aarhus University, Aarhus, Denmark. srp@biomed.au.dk.
Center for Immunology of Viral Infections, Aarhus, Denmark. srp@biomed.au.dk.
Department of Rheumatology and Inflammation Research, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Göteborg, Sweden. srp@biomed.au.dk.

Classifications MeSH